2020 New Horizons Opening Remarks - Adrienne Graves, PhD
Adrienne Graves, PhD is co-chair and co-founder of Glaucoma 360 (along with Andrew Iwach, MD). In this video, Dr. Graves gives the welcome and opening remarks at the 9th Annual Glaucoma 360 - New Horizons Forum in San Francisco on February 7, 2020 at the Grand Hyatt San Francisco. Website: glaucoma360.org
2020 New Horizons Keynote Lecture - David W. Parke II, MD
“When Cost and Innovation Collide in Ophthalmology.” David W. Parke II, MD (Chief Executive Officer, American Academy of Ophthalmology) delivered the Drs. Henry and Frederick Sutro Memorial Lecture at the 9th annual Glaucoma 360 New Horizons Forum in San Francisco on February 7, 2020. The keynote started a full day of presentations and panel discussions on innovations in glaucoma drug delivery, pharmaceuticals, and devices. New Horizons Forum is presented by Glaucoma Research Foundation (GRF), a national nonprofit based in San Francisco, CA. Website: glaucoma.org
Inder Paul Singh, MD - New Devices in Glaucoma 2020
We interviewed Inder Paul Singh, MD (The Eye Centers of Racine and Kenosha) about "New Devices in Glaucoma" at the Glaucoma 360 New Horizons Forum in San Francisco on February 7, 2020. Dr. Singh discusses the benefits of new laser treatments such as SLT and new MIGS (Micro-Invasive Glaucoma Surgery) options for early intervention in glaucoma treatment. Glaucoma 360 is presented annually by Glaucoma Research Foundation, a nonprofit organization based in San Francisco, CA. Website: glaucoma360.org
Non-IOP Lowering Glaucoma Treatments - New Horizons Forum 2020
Ahmara Gibbons Ross, MD, PhD (University of Pennsylvania) and Sunita Radhakrishnan, MD (Glaucoma Center of San Francisco) discuss new non-IOP-lowering glaucoma treatments in the pipeline (in development, but not yet ready for use by glaucoma patients). These innovative new approaches to glaucoma treatment include neuroenhancement, neuroregeneration, and neuroprotection as a new way to prevent vision loss and potentially even restore lost vision in glaucoma patients. Ahmara and Sunita co-moderated the session on Non-IOP Lowering Glaucoma Treatments at New Horizons Forum in San Francisco on February 7, 2020. Website: glaucoma360.org
Christy Shaffer, PhD discusses Early-Stage Glaucoma Financing
Christy Shaffer, PhD was co-moderator of the session "Show Me The Money — Getting to Go in Early Stage Glaucoma Financing" at the 9th Annual Glaucoma 360 New Horizons Forum on February 7, 2020 in San Francisco. In this video interview with Glaucoma Research Foundation, she discusses the process of taking an idea from an academic environment to a new solution for helping glaucoma patients. Website: glaucoma360.org
Tosin Smith, MD discusses Glaucoma Pharmaceuticals: What's New on the Horizon?
Oluwatosin Smith, MD (Glaucoma Associates of Texas) co-moderated the 2020 New Horizons Forum industry panel discussion on glaucoma pharmaceuticals. In this exclusive interview with Glaucoma Research Foundation, Dr. Tosin Smith discusses the main takeaway messages from the session at Glaucoma 360 in San Francisco, and her vision for the future of pharmaceutical treatments for glaucoma.